These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 657087)

  • 1. Delayed hypersensitivity and lymphocytic transformation in patients with Hodgkin's disease and granulomas.
    Pick AI; Duer D; Kessler H; Kenan Z; Weiss H; Topilski M
    Cancer; 1978 Jun; 41(6):2192-6. PubMed ID: 657087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelioid granulomas associated with Hodgkin's disease: clinical correlations in 55 previously untreated patients.
    Sacks EL; Donaldson SS; Gordon J; Dorfman RF
    Cancer; 1978 Feb; 41(2):562-7. PubMed ID: 630538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 7. Phytohemagglutinin skin tests in cancer patients.
    Zuckerman KS; LoBuglio AF
    Cancer; 1977 Jun; 39(6):2355-61. PubMed ID: 266970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer factor in Hodgkin's disease.
    Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
    Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival.
    Young RC; Corder MP; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):446-54. PubMed ID: 4574227
    [No Abstract]   [Full Text] [Related]  

  • 11. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrinsic lymphocyte defect in Hodgkin's disease: analysis of the phytohemagglutinin dose-response.
    Ziegler JB; Hansen P; Penny R
    Clin Immunol Immunopathol; 1975 Mar; 3(4):451-60. PubMed ID: 803886
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte transformation caused by PHA and PPD in patients with Hodgkin's disease and its correlation with clinical and hematological aspects].
    Tognella S; Mantovani G; Malloci A; Del Giacco GS; Manconi PE; Grifoni V
    Haematologica; 1972; 57(9):552-5. PubMed ID: 4199311
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
    Wagener DJ; Geestman E; Wessels HM
    Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological defects in healthy twin siblings to patients with Hodgkin's disease.
    Björkholm M; Holm G; De Faire U; Mellsted H
    Scand J Haematol; 1977 Oct; 19(4):396-404. PubMed ID: 562530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological competence in Hodgkin's disease].
    Lang JM
    Pathol Biol (Paris); 1973 Mar; 21(3):285-97. PubMed ID: 4145143
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired lymphocyte function in untreated Hodgkin's disease.
    Levy R; Kaplan HS
    N Engl J Med; 1974 Jan; 290(4):181-6. PubMed ID: 4203007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.